DILAFOR
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. The company’s primary goal is to decrease the incidence of slow progress of labor both after induction of labor and after spontaneous onset of labor.
DILAFOR
Industry:
Biopharma Pharmaceutical
Founded:
2003-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.dilafor.com
Total Employee:
11+
Status:
Active
Contact:
+46 70 790 02 07
Total Funding:
51 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Microsoft Azure DNS Fonts.com
Similar Organizations
Current Employees Featured
Founder
Investors List
Praktikerinvest
Praktikerinvest investment in Venture Round - Dilafor
Rosetta Capital
Rosetta Capital investment in Venture Round - Dilafor
Ostersjöstiftelsen
Ostersjöstiftelsen investment in Venture Round - Dilafor
Official Site Inspections
http://www.dilafor.com
- Host name: dedserv4081.levonline.com
- IP address: 217.70.37.81
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Dilafor"
Our company - Dilafor AB
Dilafor AB Karolinska Institutet Science Park Fogdevreten 2A, SE-171 65 Solna Sweden For email contact, [email protected] Lena Degling Wikingsson, CEO Mobile …See details»
Dilafor - Crunchbase Company Profile & Funding
Organization. Dilafor . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Dilafor AB is a Swedish drug development company focusing on the development of …See details»
Management - Dilafor AB
Dilafor AB Karolinska Institutet Science Park Fogdevreten 2A, SE-171 65 Solna Sweden For email contact, [email protected] Lena Degling Wikingsson, CEO Mobile …See details»
Dilafor AB Company Profile | Solna, Stockholm, Sweden
Find company research, competitor information, contact details & financial data for Dilafor AB of Solna, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Dilafor Company Profile 2024: Valuation, Funding & Investors
Dilafor General Information Description. Producer of pharmaceutical products intended to contribute towards healthy lives for mothers, children, and families. The company's products …See details»
Dilafor Company Profile - Office Locations, Competitors ... - Craft
Dilafor is a company that develops pharmaceutical products aimed at minimizing the risk of protracted labor and associated complications. It offers Tafoxiparin, a heparan sulfate mimetic, …See details»
Dilafor - Crunchbase
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.See details»
Dilafor - Funding, Financials, Valuation & Investors - Crunchbase
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Dilafor - Karolinska Development
Dilafor AB is a women’s health company based in Stockholm, Sweden, developing tafoxiparin for obstetric indications, with particular reference to protracted labor and associated …See details»
Medical need and indication - Dilafor AB
Dilafor AB Karolinska Institutet Science Park Fogdevreten 2A, SE-171 65 Solna Sweden For email contact, [email protected] Lena Degling Wikingsson, CEO Mobile +46707900207 Hanna Ersson, Assistant Phone …See details»
Karolinska Development’s portfolio company Dilafor recruits
Oct 27, 2021 Dilafor has now enrolled the first patient in a Phase 2a pilot study that will investigate whether treatment with subcutaneously administered tafoxiparin can improve the …See details»
Karolinska Development’s portfolio company Dilafor has
Dec 27, 2022 STOCKHOLM, SWEDEN – December 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has enrolled …See details»
Dilafor - Contacts, Employees, Board Members, Advisors & Alumni
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications.See details»
Our Vision - Dilafor AB
Dilafor AB Karolinska Institutet Science Park Fogdevreten 2A, SE-171 65 Solna Sweden For email contact, [email protected] Lena Degling Wikingsson, CEO Mobile …See details»
Karolinska Development’s portfolio company Dilafor has …
Dec 27, 2022 STOCKHOLM, SWEDEN – December 27, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has enrolled …See details»
Karolinska Development’s portfolio company Dilafor recruits first ...
Oct 27, 2021 Dilafor has now enrolled the first patient in a Phase 2a pilot study that will investigate whether treatment with subcutaneously administe. STOCKHOLM, SWEDEN – …See details»
How it works - Dilafor AB
Dilafor AB Karolinska Institutet Science Park Fogdevreten 2A, SE-171 65 Solna Sweden For email contact, [email protected] Lena Degling Wikingsson, CEO Mobile …See details»
Karolinska Development’s portfolio company Dilafor recruits first ...
Oct 27, 2021 Dilafor has now enrolled the first patient in a Phase 2a pilot study that will investigate whether treatment with subcutaneously administered tafoxiparin can improve the …See details»
Research & Development - Dilafor AB
Dilafor AB Karolinska Institutet Science Park Fogdevreten 2A, SE-171 65 Solna Sweden For email contact, [email protected] Lena Degling Wikingsson, CEO Mobile …See details»